PAK2 and non-small cell lung carcinoma: We found miR-1287-5p re-expression suppressed cell proliferation (Figure 7(a–c)), migration, and invasion abilities (Figure 7(d,e)), cell cycle (Figure 7(f,g)), and tube formation (Figure 7h) and enhanced apoptosis (Figure 7(i–k)) in A549 and H1299 cells, while PAK2 overexpression attenuated these anticancer effects induced by miR-1287-5p re-expression in NSCLC cells (Figure 7(a–k)).